1MED SA – Trademark Portfolio

Entity Type: 99

1MED SA holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include 1 SURVEY.

Via Campagna 13

CH-6982 Agno

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

1 FILE
1 FILE
Abandoned 2022
1 SURVEY
1 SURVEY
Registered 2022
TRIAL
TRIAL
Abandoned 2022
DATA
DATA
Abandoned 2022

Trademark Classifications

1MED SA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

38
Telecommunications (4 filings)

Telecommunications

Frequently Asked Questions

How many trademarks does 1MED SA have?

1MED SA has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.

What trademark classes does 1MED SA file in?

1MED SA files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.

What are 1MED SA's most well-known trademarks?

1MED SA's registered trademark portfolio includes well-known marks such as 1 SURVEY. These are among 1 currently registered trademark in the portfolio.

What is 1MED SA's trademark registration success rate?

1MED SA has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.